e-learning
resources
Munich 2006
Sunday 03.09.2006
Outcomes of anti-tuberculosis treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The relationship between extension of disease in the patients with smear positive pulmonary tuberculosis and hepatotoxicity
D. Tas, A. Ilvan, O. Sezer, F. Ciftci, E. Bozkanat, M. Bicak, Z. Kartaloglu (Istanbul, Turkey)
Source:
Annual Congress 2006 - Outcomes of anti-tuberculosis treatment
Session:
Outcomes of anti-tuberculosis treatment
Session type:
E-Posters in free access
Number:
151
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Tas, A. Ilvan, O. Sezer, F. Ciftci, E. Bozkanat, M. Bicak, Z. Kartaloglu (Istanbul, Turkey). The relationship between extension of disease in the patients with smear positive pulmonary tuberculosis and hepatotoxicity. Eur Respir J 2006; 28: Suppl. 50, 151
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Treatment outcomes of smear positive pulmonary tuberculosis cases
Source: Eur Respir J 2005; 26: Suppl. 49, 647s
Year: 2005
The rate of tuberculosis infection in closed contacts of smear positive pulmonary tuberculosis patients
Source: Eur Respir J 2002; 20: Suppl. 38, 474s
Year: 2002
Comparison of smear positive tuberculosis features in males with and without chronic lung diseases
Source: Annual Congress 2010 - Adverse events of antituberculosis treatment and comorbidities
Year: 2010
Over diagnosis of smear negative pulmonary tuberculosis in patients with allergic bronchopulmonary aspergillosis: A study from high tuberculosis burden country
Source: International Congress 2019 – Tuberculosis and comorbidities
Year: 2019
Diagnosis problem in smear negative pulmonary tuberculosis: study about 34 cases
Source: Annual Congress 2009 - Diagnostic advances in tuberculosis
Year: 2009
A T-cell-based assay for rapid diagnosis of difficult cases of tuberculosis (TB): smear negative pulmonary and extra-pulmonary TB
Source: Eur Respir J 2005; 26: Suppl. 49, 240s
Year: 2005
Brochoscopic finding in sputum negative pulmonary tuberculosis
Source: Annual Congress 2007 - Epidemiology of tuberculosis II
Year: 2007
Cryobiopsy in diagnosis of smear negative pulmonary tuberculosis (SNPTB)
Source: International Congress 2018 – Cryobiopsy in interstitial lung disease (ILD)
Year: 2018
Smear negative pulmonary tuberculosis in HIV: Over diagnosed or under investigated
Source: Annual Congress 2012 - Tuberculosis: clinical findings III
Year: 2012
Is smear negativity for pulmonary tuberculosis associated with a history of previous incomplete treatment?
Source: Annual Congress 2007 - Tuberculosis
Year: 2007
The profile of patients with pulmonary and extrapulmonary tuberculosis
Source: Eur Respir J 2001; 18: Suppl. 33, 312s
Year: 2001
The ratio of positive smears and cultures in diagnosis of pulmonary tuberculosis and tuberculous pleurisy
Source: Eur Respir J 2003; 22: Suppl. 45, 162s
Year: 2003
Pulmonary disease caused by M. malmoense in HIV negative patients: 5-yr follow-up of patients receiving standardised treatment
Source: Eur Respir J 2003; 21: 478-482
Year: 2003
Decision to treat of smear negative pulmonary tuberculosis
Source: Annual Congress 2008 - Problems in managing pulmonary and extrapulmonary tuberculosis
Year: 2008
Endobrochites of specific genesis in patients with pulmonary tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 201s
Year: 2004
Tuberculosis of the skin in the patient with positive familiar history to pulmonary tuberculosis
Source: Eur Respir J 2007; 30: Suppl. 51, 88s
Year: 2007
Peculiarities in implementation of national tuberculosis program in patients with smear negative pulmonary tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 190s
Year: 2004
Factors that affect sputum smear and culture conversion in patients with smear positive pulmonary tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 428s
Year: 2005
Value of third sputum specimen for microscopic detection of pulmonary tuberculosis in HIV infected patients
Source: Annual Congress 2011 - Tuberculosis in immunocompromised hosts
Year: 2011
The frequency of cases of hepatotoxic reactions in first diagnosed patients with pulmonary tuberculosis
Source: International Congress 2018 – Challenges in treating tuberculosis and nontuberculous mycobacteria
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept